Remepan® offers additional benefits beyond HbA1c control, including increased weight loss and improvements to the cardiovascular and renal systems, decreasing morbidity and mortality for type 2 diabetes patients.
Remepan® offers additional benefits beyond HbA1c control, including increased weight loss and improvements to the cardiovascular and renal systems, decreasing morbidity and mortality for type 2 diabetes patients.
For patients with type 2
Remepan® is an oral once-daily treatment, which can be consumed with or without food. Many patients prefer oral treatments over injectables, improving overall adherence to treatment to other type 2 diabetes medications.
Additional benefits with Remepan®
A sodium-glucose co-transporter 2 (SLGT2) Inhibitor indicated as an adjunct diet and exercise.
HbA1C levels
lowered HbA1C levels when added to metformin vs metformin and placebo (p<0.0001)
Weight loss
secondary benefit when added to metformin vs metformin plus placebo
Clinical care
possibility of SGLT2 inhibitors to improve cardiovascular and renal health outcomes
Remepan® is beneficial to improve glycemic control in adults with type 2 diabetes.
Many patients prefer oral treatments over injectables, improving overall adherence to treatment to diabetes type 2 medications such as Remepan® 5mg and Remepan® 10mg.